{
    "clinical_study": {
        "@rank": "84061", 
        "arm_group": {
            "arm_group_label": "Plasmafit\u00ae Total Hip Arthroplasty"
        }, 
        "brief_summary": {
            "textblock": "Twelve months follow-up of implant survival and clinical and radiological follow-up of\n      Plasmafit\u00ae Cup."
        }, 
        "brief_title": "Post Market Clinical Follow-Up of Plasmafit\u00ae Cup", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Total Hip Arthroplasty", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Minimum age 18 years\n\n          -  Indication for cementless total hip arthroplasty\n\n          -  Patient consent for study participation\n\n          -  Physical and mental willingness to participate at clinical and radiological follow-up\n\n        Exclusion Criteria:\n\n          -  Patient not available for follow-up\n\n          -  Increased anesthetics risks according to the \"American Society of Anesthesiology\":\n             ASA IV\n\n          -  Tumor\n\n          -  Alcohol or drug abuse\n\n          -  Permanent cortisone therapy\n\n          -  Clinically relevant infection\n\n          -  Pregnancy or planned pregnancy\n\n          -  Prior interventions like osteotomy, fracture treatment or prior THA at the concerned\n             hip\n\n          -  Acute fracture at the concerned hip\n\n          -  Patients needing a cemented hip arthroplasty"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Specialist  Clinical Centre"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019849", 
            "org_study_id": "AAG-O-H-1213"
        }, 
        "intervention": {
            "arm_group_label": "Plasmafit\u00ae Total Hip Arthroplasty", 
            "description": "N/A", 
            "intervention_name": "Plasmafit\u00ae Total Hip Arthroplasty", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "THA, Plasmafit\u00ae", 
        "lastchanged_date": "December 18, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bad Rappenau", 
                        "country": "Germany"
                    }, 
                    "name": "Vulpius-Klinik Bad Rappenau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stuttgart", 
                        "country": "Germany"
                    }, 
                    "name": "Diakonie-Klinikum Stuttgart"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Implant survival is analysed at follow-up examinations at 3 months, 12 months, 5 years and 10 years", 
            "measure": "Implant Survival Rates", 
            "safety_issue": "No", 
            "time_frame": "10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019849"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Radiological Outcome", 
                "measure": "Osteolysis", 
                "safety_issue": "No", 
                "time_frame": "3 months, 12 months, 5 years, 10 years"
            }, 
            {
                "description": "Radiological Outcome", 
                "measure": "Ossifications", 
                "safety_issue": "No", 
                "time_frame": "3 months, 12 months, 5 years, 10 years"
            }, 
            {
                "description": "Radiological Outcome", 
                "measure": "Implant Position", 
                "safety_issue": "No", 
                "time_frame": "3 months, 12 months, 5 years, 10 years"
            }, 
            {
                "description": "Radiological Outcome", 
                "measure": "Migration of Plasmafit\u00ae", 
                "safety_issue": "No", 
                "time_frame": "3 months, 12 months, 5 years, 10 years"
            }, 
            {
                "description": "Harris Hip Score", 
                "measure": "Clinical Outcome", 
                "safety_issue": "No", 
                "time_frame": "3 months, 12 months, 5 years, 10 years"
            }
        ], 
        "source": "Aesculap AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aesculap AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}